OragenicsOGEN
13F holders, Q1 2026 (March 31)20holders +1
12new positions
9sold out
$0.56avg. 13F price*
At the end of Q1 2026, 20 institutions reported holding Oragenics Inc. (OGEN) in their 13F filings, up 1 from Q4 2025. 12 opened new positions and 9 sold out. The largest holders were Geode Capital Management, LLC ($36K), Pathstone Holdings, LLC ($31K) and Two Sigma Securities, LLC ($11K).
- Company
- Oragenics Inc.
- CUSIP
- 684023609
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $100K |
| Exits | 9 | $163K |
All 13F filers, Q4 2025 → Q1 2026: 181,679 shares bought and 208,382 shares sold, net −26,703 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Geode Capital Management, LLC | 0.00% | New | 65,072 | $36K |
| Pathstone Holdings, LLC | 0.00% | New | 55,001 | $31K |
| Two Sigma Securities, LLC | 0.00% | New | 20,343 | $11K |
| Virtu Financial LLC | 0.00% | New | 17,575 | $10K |
| HRT Financial LP | 0.00% | New | 18,672 | $10K |
| UBS Group AG | 0.00% | Add +117.4% | 5,205 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.1% | 4,548 | $3K |
| Ameritas Advisory Services, LLC | 0.00% | New | 2,000 | $1K |
| BlackRock, Inc. | 0.00% | No change | 703 | $394 |
| St. Johns Investment Management Company, LLC | 0.00% | New | 200 | $112 |
| Wells Fargo & Company | 0.00% | No change | 34 | $19 |
| Harbour Investments, Inc. | 0.00% | No change | 34 | $19 |
| SBI Securities Co., Ltd. | 0.00% | Add +10.0% | 11 | $6 |
| Adkins Seale Capital Management LLC | 0.00% | No change | 3 | $2 |
| Johnson Financial Group, Inc. | 0.00% | New | 1 | $1 |
| Bogart Wealth, LLC | 0.00% | New | 1 | $1 |
| Strategic Wealth Partners, Ltd. | 0.00% | No change | 1 | $1 |
| Farther Finance Advisors, LLC | 0.00% | New | 1 | $1 |
| Keating Financial Advisory Services, Inc. | 0.00% | New | 1 | $1 |
| Royal Bank of Canada | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is OGEN's weight in each manager's 13F, not the share of Oragenics Inc. the manager owns.